Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)
Close on Nov 17, 2026Market cap $458.11MP/E –Yield –
Assembly Biosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2010 it was $419.38K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2010 | Dec 31, 2010 | $419.38K | – |
See a number that looks wrong?